TY  - JOUR
AU  - Ferreira, João Pedro
AU  - Rossello, Xavier
AU  - Pitt, Bertram
AU  - Rossignol, Patrick
AU  - Zannad, Faiez
PY  - 2019
DO  - 10.1002/clc.23261
SN  - 0160-9289
UR  - http://hdl.handle.net/20.500.12105/8582
AB  - BACKGROUND: Trials using mineralocorticoid receptor antagonists (MRAs) in myocardial infraction (MI) without heart failure (HF) or systolic impairment have been underpowered to assess morbidity-mortality benefit. In EPHESUS 6632 patients were...
LA  - eng
PB  - Wiley
KW  - Ejection fraction
KW  - Eplerenone
KW  - Mineralocorticoid receptor antagonists
KW  - Myocardial infarction
KW  - Treatment effect
TI  - Eplerenone in patients with myocardial infarction and "mid-range" ejection fraction: An analysis from the EPHESUS trial
TY  - journal article
ER  -